BioPharma Drug Discovery

AbbVie Secures EU Approval for TEPKINLY® as First Subcutaneous Bispecific Antibody for Relapsed Follicular Lymphoma

AbbVie announced that the European Commission (EC) has granted conditional marketing authorization for TEPKINLY® (epcoritamab) as a monotherapy fo...

 August 20, 2024 | News

AbbVie Secures EU Approval for TEPKINLY® as First Subcutaneous Bispecific Antibody for Relapsed Follicular Lymphoma

AbbVie announced that the European Commission (EC) has granted conditional marketing authorization for TEPKINLY® (epcoritamab) as a monotherapy fo...

 August 20, 2024 | News

Astellas Pharma Gains NMPA Approval for PADCEV™ in China to Treat Advanced Urothelial Cancer

Astellas Pharma Inc. (TSE:4503, President and CEO: Naoki Okamura, "Astellas")  announced that the Center for Drug Evaluation (CDE) of C...

 August 20, 2024 | News

Akeso’s Ivonescimab Granted Priority Review by China's NMPA for First-Line Treatment of PD-L1 Positive NSCLC

Akeso, Inc. announced that the National Center for Drug Evaluation of the State Drug Administration of the People's Republic of China (NMPA CDE) ...

 August 15, 2024 | News

AI Meets Life Sciences: How HKSTP and BioMap Are Transforming Hong Kong’s Biotech Landscape

In an exclusive interview with BioPharma APAC, Dr. Grace Lau, Head of Institute for Translational Research at Hong Kong Science and Technology Parks Corpor...

 August 14, 2024 | Interview

UAE Approves LEQEMBI® for Early Alzheimer’s Treatment, Marking a Milestone in Regional Healthcare

Eisai Co., Ltd. and Biogen Inc. announced today that the Ministry of Health and Prevention in the United Arab Emirates (UAE) has approved humanized anti-so...

 August 14, 2024 | News

Sable Therapeutics Secures Exclusive Worldwide Licensing Deal with Columbia University to Advance Cutting-Edge Fat Reduction Nanomedicines

Sable Therapeutics, an innovative early stage drug development company focused on pioneering fat reduction therapies,  announced an exclusive worldwid...

 August 12, 2024 | News

Formosa Pharmaceuticals and Eyenovia to Co-Develop Clobetasol Propionate for Dry Eye Disease

Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TWO) announced today that the company has signed a non-binding terms agreement with Eyenovia, Inc. ("...

 August 08, 2024 | News

Senhwa Biosciences Receives FDA Green Light for Phase I/II Trial of Silmitasertib in Pediatric Relapsed Refractory Solid Tumors

Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious disea...

 August 07, 2024 | News

Cresset and Enamine Expand Global Collaboration to Enhance Targeted Protein Degradation Research

Cresset, an innovative provider of integrated in silico solutions for drug discovery, announces an extension of the global collaboration with Ena...

 August 06, 2024 | News

Medicilon and Hengrui Pharma Forge Strategic Partnership to Accelerate Preclinical Drug Development

Shanghai Medicilon Inc. ("Medicilon") and Jiangsu Hengrui Pharmaceuticals Co., Ltd. ("Hengrui Pharma") reached a strategic collaboration agreement.&nb...

 August 01, 2024 | News

$2 Million Grant Fuels Queensland Drug Discovery Alliance to Propel Therapeutic Innovations

A $2 million grant awarded to establish the Queensland Drug Discovery Alliance (QDDA) will align and grow Queensland’s small molecule therapeutic dis...

 July 31, 2024 | News

Clarivate Launches Enhanced OFF-X™ Platform to Transform Drug Safety Intelligence

Clarivate Plc  a leading global provider of transformative intelligence, today announced the launch of the new OFF-X™ platform. The en...

 July 31, 2024 | News

ReviR Therapeutics Secures $30M Series A Financing to Advance AI-Driven RNA Modulator Platform

ReviR Therapeutics, an AI-enabled biotechnology company focused on developing small molecule RNA modulators for neurogenetic diseases, announced today that...

 July 29, 2024 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close